Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03812107 · ClinicalTrials.gov registry record · NA
Response to Relapse in Office-Based Opioid Treatment Trial
A NA study, sponsored by Boston Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT03812107 is a NA study that was terminated before completion, run by Boston Medical Center. The registered enrollment target is 115 participants.
The verdict
NCT03812107, a NA study, was terminated before completion, sponsored by Boston Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
In a sample of individuals with co-occurring OUD and mental disorders, the investigators plan to test two medications for opioid use disorder (MOUD) treatment protocols that involve differing approaches to the use of opioids and other drugs during and after stabilization on MOUD - intensive vs. moderate treatment.The study is being conducted alongside the opening of a new clinical service funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) known as the Addiction and Behavioral Health Outpatient Recovery (ABOVE) program. The ABOVE Program is designed to treat patients with co-occurring opioid use disorder (OUD) and mental disorders with MOUD. Participants are individuals seeking treatment for co-occurring opioid use disorder (OUD) and mental disorders and are willing to receive MOUD treatment. Potential participants will be screened in the context of clinical care for opioid use disorder and mental disorders. If they are eligible for treatment in the ABOVE program, they will be asked to complete a baseline assessment, again for the purposes of clinical care. After completing the baseline clinical assessment, they will be asked to participate in this clinical trial, consented, then randomized. Treatment is delivered in the context of clinical care which involves delivery of MOUD and can involve psychiatric medications, and group and individual psychotherapy. Difference in treatment between the two randomization arms will only occur if a relapse to drug use occurs and will only involve two protocol-directed treatment responses to relapse.
Interventions
- OTHER Moderate Treatment Approach
- OTHER Intensive Treatment Approach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2019-02-07 |
| Est. Completion | 2020-03-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03812107
The ClinicalTrials.gov registry entry for NCT03812107 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Moderate Treatment Approach is the first listed.
NCT03812107 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03812107 about?
NCT03812107 is a clinical study titled "Response to Relapse in Office-Based Opioid Treatment Trial". In a sample of individuals with co-occurring OUD and mental disorders, the investigators plan to test two medications for opioid use disorder (MOUD) treatment protocols that involve differing approaches to the use of opioids and other drugs during and after stabilization on MOUD - intensive vs. mode...
What is the current status of trial NCT03812107?
This trial is currently terminated. It is a NA study. The enrollment target is 115 participants. The study started on 2019-02-07. Estimated completion is 2020-03-12.
What interventions are being tested in trial NCT03812107?
The interventions under investigation include: Moderate Treatment Approach (OTHER), Intensive Treatment Approach (OTHER).
Who is sponsoring clinical trial NCT03812107?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.